You took a medication because a doctor prescribed it and a manufacturer said it was safe.
Instead of helping you, it caused serious harm. Side effects that were never disclosed. Injuries that were known to the manufacturer and hidden anyway. A medical condition that changed your life in ways you never anticipated when you filled that prescription.
Defective drug lawsuits are among the most complex and lengthy cases in personal injury law. Pharmaceutical companies have billions of dollars and experienced legal teams defending their products. These cases take years to resolve. And while your attorney fights through that process, your medical bills, lost income, and everyday expenses do not pause.
We provide defective drug lawsuit funding to plaintiffs with pending pharmaceutical injury claims. You get cash now while your case works through the legal process. You repay only when your case resolves in your favor. If it does not, you owe us nothing.
What Is Defective Drug Lawsuit Funding?
Defective drug lawsuit funding is a pre-settlement cash advance tied to your pending pharmaceutical liability claim.
It is not a bank loan. We advance you money based on the expected value of your case. Repayment comes from your settlement proceeds when your case closes, not your personal finances. If your case does not pay out, you owe us nothing.
This type of funding is also known as:
- Pharmaceutical lawsuit pre-settlement funding
- Defective medication lawsuit advances
- Non-recourse drug injury claim funding
- Mass tort pharmaceutical settlement advances
No monthly payments. No credit checks. No employment verification required. Your case and your attorney are the only qualifications that matter.
Who Qualifies for Defective Drug Lawsuit Funding?
You may qualify if you have a pending defective drug or pharmaceutical liability lawsuit and an attorney actively representing you.
Common qualifying situations include:
- Prescription drugs that caused undisclosed or understated side effects
- Medications that caused organ damage including liver, kidney, or heart injury
- Cancer-causing drugs where the risk was known and concealed
- Blood thinners and cardiovascular medications causing serious bleeding events
- Diabetes medications linked to ketoacidosis, kidney failure, or amputations
- Antidepressants and psychiatric medications causing severe adverse reactions
- Hormone therapy drugs linked to cancer or cardiovascular disease
- Weight loss medications causing heart valve damage or pulmonary hypertension
- Opioid addiction and dependency claims against manufacturers and distributors
- Antibiotic medications causing permanent nerve damage or tendon rupture
- Birth defect claims from medications taken during pregnancy
- Over-the-counter medications causing serious undisclosed adverse effects
- Generic drug liability claims
- Cases filed as part of mass tort litigation involving multiple plaintiffs
If your attorney believes your case has merit and a likely recovery, we can typically make a funding decision within 24 hours of reviewing your claim.
How Our Defective Drug Funding Process Works
We make the process as fast and simple as possible.
Step 1: Call or apply online Reach us at 800-961-8924 or submit a short online application. No paperwork or medical records needed from you to get started.
Step 2: We contact your attorney Our team reaches out directly to your legal representative to review your case details. You do not need to gather records or coordinate anything. We handle it entirely.
Step 3: You receive your funds Once approved, we send money directly to you. Most clients receive funds the same day or the very next business day after approval.
No upfront fees. No hidden costs. No surprises.
Defective Drug Cases We Are Currently Funding
We actively fund plaintiffs in pharmaceutical liability cases across the country. Here are the cases we are currently supporting:
High-Volume Cases
Ozempic, Wegovy, and Mounjaro
GLP-1 receptor agonist medications prescribed for diabetes and weight loss have been linked to gastroparesis, also called stomach paralysis, and other severe gastrointestinal injuries. Plaintiffs are alleging that manufacturers failed to adequately warn patients and healthcare providers about the risk of these serious and potentially permanent conditions.
Hair Relaxer Products
Women who used chemical hair relaxer products over extended periods have filed lawsuits alleging the products caused uterine cancer, ovarian cancer, and endometriosis. Research has linked certain chemicals in these products to hormone disruption and increased cancer risk. This litigation has grown significantly and continues to expand.
Tylenol and Acetaminophen Used During Pregnancy
Lawsuits filed on behalf of children allege that prenatal exposure to acetaminophen is linked to autism spectrum disorder and ADHD. Parents who used the medication during pregnancy as directed are pursuing claims against manufacturers for failing to warn about these developmental risks.
Tepezza
Tepezza, a medication used to treat thyroid eye disease, has been linked to permanent hearing loss and tinnitus in some patients. Plaintiffs allege that the manufacturer knew about these risks and failed to adequately disclose them to patients and prescribing physicians.
Bard PowerPort
The Bard PowerPort is an implantable catheter device used to deliver chemotherapy and other intravenous medications. Plaintiffs have reported catheter fractures, device migration, and serious internal injuries caused by device failure. Lawsuits allege defective design and inadequate warnings.
Established Pharmaceutical Litigation
Paraquat
Agricultural workers and others exposed to paraquat, a widely used herbicide, have filed lawsuits linking the chemical to Parkinson’s disease. Plaintiffs allege that manufacturers knew about the connection between paraquat exposure and neurological harm for decades and failed to warn users adequately.
Zantac and Ranitidine
Zantac and its generic equivalents were found to contain NDMA, a known carcinogen, that could build to dangerous levels over time. Plaintiffs who developed cancer after long-term use are pursuing claims against manufacturers for selling a product that degraded into a cancer-causing substance.
Prilosec and Nexium
Long-term use of proton pump inhibitors including Prilosec and Nexium has been linked to kidney damage and chronic kidney disease. Plaintiffs allege that manufacturers knew about these risks and failed to adequately disclose them on product labels and prescribing information.
Xarelto
Xarelto, a blood thinner prescribed to reduce stroke and blood clot risk, was linked to cases of severe uncontrolled bleeding. Unlike older blood thinners, Xarelto initially lacked a reversal agent, meaning patients who experienced serious bleeding events had very limited treatment options. Significant litigation and settlements have followed.
Valsartan
Valsartan, a blood pressure medication, was found to be contaminated with NDMA and other carcinogens during the manufacturing process. Multiple recalls followed and plaintiffs who developed cancer are pursuing claims against manufacturers and distributors for the contaminated product.
Talcum Powder
Talcum powder products have been linked to ovarian cancer and mesothelioma in women who used them for personal hygiene over extended periods. Significant litigation and multi-billion dollar verdicts have followed, with major manufacturers facing thousands of individual claims.
Do not see your case listed? Call us at 800-961-8924. We evaluate all types of pharmaceutical liability claims including class action lawsuits and individual personal injury cases. If your case has merit and legal representation, we want to talk.
Why Defective Drug Cases Take So Long
Pharmaceutical litigation moves slowly by almost any measure. Understanding why helps explain why financial support during the process is so important for plaintiffs.
Pharmaceutical companies have enormous resources
The largest drug manufacturers in the world generate billions of dollars in annual revenue. They retain the most experienced product liability defense firms available. Their legal strategy in defective drug litigation is built around delay, challenge, and attrition. They know that many plaintiffs cannot afford to wait years for resolution and they use that financial pressure deliberately.
Scientific and medical evidence is contested
Proving that a specific drug caused your specific injury requires detailed scientific and medical evidence. Your attorney needs expert witnesses including pharmacologists, toxicologists, and treating physicians who can establish causation to the legal standard required. Gathering, analyzing, and presenting that evidence takes significant time and resources.
Mass tort proceedings have their own timelines
Most significant defective drug cases are litigated as mass torts involving thousands of plaintiffs. These cases are typically consolidated before a single federal judge in multidistrict litigation proceedings. The MDL process involves coordinated discovery, bellwether trials, and global settlement negotiations that unfold on a timeline individual plaintiffs have very little control over.
Regulatory history requires deep investigation
Building a strong defective drug case requires thorough investigation of the manufacturer’s regulatory history. FDA approval records, internal communications, clinical trial data, adverse event reports, and correspondence between the manufacturer and federal regulators are all potentially relevant. Obtaining and analyzing this documentation takes time and legal resources.
Settlement negotiations in mass torts are complex
When thousands of plaintiffs are pursuing claims against the same manufacturer, settlement negotiations happen at a global level that affects individual outcomes. Your attorney is working to maximize your individual recovery within that broader negotiation structure. That process does not move quickly.
Our funding exists specifically to carry plaintiffs financially through this timeline. The process will take as long as it takes. You should not have to settle for less because you cannot afford to wait.
The Financial Reality Pharmaceutical Injury Victims Face
Defective drug injuries are not minor inconveniences. They are life-altering medical events that carry substantial financial consequences.
The medication was supposed to treat a condition. Instead it created new ones. Additional medical treatment to address drug-induced injuries adds costs on top of whatever the original condition was already costing. Specialist consultations, diagnostic testing, surgical interventions, and ongoing management of drug-induced conditions all add up quickly.
Many pharmaceutical injury victims experience disruptions to their employment because of the severity of their drug-induced conditions. Lost wages during treatment, reduced earning capacity from permanent injuries, and career disruption from extended medical leave all have real financial impact.
Meanwhile the pharmaceutical company’s legal team is working every day to minimize what they owe you. They are counting on the combination of time and financial pressure to push you toward accepting a settlement that does not reflect the true cost of your injuries.
Our funding removes that pressure. When your immediate financial needs are covered, your attorney can take the time the case requires to fight for what it is actually worth.
Mass Tort Pharmaceutical Litigation Explained
If your defective drug case involves the same medication as thousands of other plaintiffs, it is likely part of or will become part of a mass tort proceeding.
Mass tort litigation consolidates individual cases involving the same product and the same type of injury before a single court for coordinated pretrial proceedings. This structure allows for more efficient handling of common issues like discovery and expert witness testimony while preserving each plaintiff’s individual right to recover based on their specific injuries and damages.
The most common federal structure for mass tort pharmaceutical cases is multidistrict litigation, or MDL. Cases are transferred to a single federal district court where a judge oversees coordinated proceedings. Bellwether trials involving representative plaintiffs test legal theories and provide guidance on settlement values. Global settlement negotiations typically follow.
Individual plaintiffs in an MDL receive their own separate settlement amount based on their individual damages, injury severity, and how their case fits within the settlement matrix negotiated by attorneys for the plaintiff group.
This process is thorough but it is not fast. Plaintiffs in pharmaceutical MDL proceedings have sometimes waited five years or more for individual resolution. Our funding is designed specifically to support plaintiffs through timelines like these.
Why Clients Choose ECO for Defective Drug Lawsuit Funding
We have been funding personal injury plaintiffs since 2010. Pharmaceutical mass tort cases require specific experience with MDL timelines, settlement matrix structures, and the unique dynamics of litigation against large corporate defendants. We bring all of that to every application.
Here is what you can expect from us:
- No repayment if you lose: Our funding is fully non-recourse
- Fast decisions: Most clients hear back within 24 hours of attorney contact
- No credit checks: Approval is based entirely on your case
- Transparent terms: No hidden fees, no surprise charges, no fine print
- Direct attorney coordination: We handle all communication with your legal team
- Mass tort experience: We understand MDL timelines and pharmaceutical settlement structures
- Current case knowledge: We actively fund plaintiffs in the largest active drug lawsuits of 2026
We are here to make a difficult situation more manageable while your attorney does the work your case requires.
How Much Can You Receive?
Funding amounts depend on the estimated value of your specific defective drug case.
We evaluate the nature and severity of your drug-induced injuries, the pharmaceutical product involved, the stage of litigation, your attorney’s assessment of your individual case value, and available defendant resources. Cases involving serious permanent injuries and clear manufacturer liability can carry substantial value.
Every case is different. The only way to know exactly what you qualify for is to call us directly. No cost. No obligation.
Call 800-961-8924 for a free, no-obligation case review.
The Drug Was Supposed to Help You. Now It Is Time to Fight Back.
You trusted a pharmaceutical company to be honest about the risks of their product. That trust was broken. Your attorney is working to hold them accountable. That fight takes time and the financial ability to see it through.
Defective drug lawsuit funding from ECO Pre-Settlement Funding gives you the stability to stay in the fight as long as it takes. No risk. No monthly payments. No repayment unless your case pays out.
Call 800-961-8924 today or apply online. Most applicants receive a funding decision within 24 hours. No cost to apply and no obligation to accept.
Frequently Asked Questions
What is defective drug lawsuit funding?
It is a pre-settlement cash advance based on the expected value of your pending pharmaceutical liability lawsuit. You repay from your settlement only if your case pays out. If it does not, you owe us nothing. No monthly payments. No credit checks.
Can I get funding if my case is part of a mass tort or MDL?
Yes. We fund individual plaintiffs in mass tort pharmaceutical litigation including MDL proceedings. Call us at 800-961-8924 to discuss where your specific case stands and what funding options are available.
Do you fund Ozempic, hair relaxer, and Tylenol prenatal cases?
Yes. These are among the high-volume cases we are actively funding in 2025 and 2026. Call us at 800-961-8924 to discuss your specific situation with our team.
Do I need an attorney to apply for defective drug lawsuit funding?
Yes. Legal representation is required to qualify. We contact your attorney directly to review your case details. You do not need to gather any documents yourself.
How quickly can I get funded after filing a defective drug lawsuit?
Most applicants receive a decision within 24 hours of us speaking with their attorney. Funds are typically delivered the same day or next business day after approval.
How much money can I get for my defective drug case?
Funding amounts vary based on injury severity, the pharmaceutical product involved, and your attorney’s assessment of your individual case value. Call 800-961-8924 for a free, no-obligation review and a funding estimate specific to your situation.